Peculiarities of the course of coronavirus infection and some aspects of treatment of geriatric patients with SARS-COV-2-induced lung damage

Abstract

Older adults are particularly susceptible to SARS-CoV-2 infection and are at significant risk of adverse clinical outcome. SARS-CoV-2-induced lung injury has its own clinical, laboratory and biochemical characteristics in the elderly and elderly. Geriatric patients with SARS-CoV-2 require an individualized approach taking into account age related changes in their body, presence of concomitant diseases, high risk of adverse reactions developing in response to drug administration. Any drug used in treatment regimens of an elderly or elderly person infected with SARS-CoV-2 requires special attention due to the age related features and polymorbidity present in the geriatric patient. Currently, there is a lack of information about all the effects that can be caused by COVID-19 infection, especially in the elderly and old. The scattered studies available do not provide a complete clinical picture of the course and treatment of COVID-19-associated pneumonia in the elderly.